I'm probably reading too much into this, but are we seeing a clue about fda that may correlate with recent advice for approval pathway of the adults app?
"Results and lessons from the research will support applications for regulatory approval..." including the FDA. We're not sure yet if clinical trials are needed for fda for the adult app - it's possible that existing trial data and that gained via paying customers could be enough for the submission. Thoughts?
I'm probably reading too much into this, but are we seeing...
-
- There are more pages in this discussion • 59 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PCK (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
3.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $49.07M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 546666 | 3.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 3.1¢ | 129158 | 2 |
View Market Depth
| Last trade - 16.33pm 27/09/2024 (20 minute delay) ? |
| PCK (ASX) Chart |
Day chart unavailable